Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis
about
Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysisDiagnosis & treatment of tuberculosis in HIV co-infected patients.Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics.Advances in addressing technical challenges of point-of-care diagnostics in resource-limited settings.The importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission modelCosts and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in IndiaOperations research in global health: a scoping review with a focus on the themes of health equity and impactField evaluation of a blood based test for active tuberculosis in endemic settingsPoor performance of serological tests in the diagnosis of pulmonary tuberculosis: evidence from a contact tracing field study.Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries.Laboratory Diagnostics Market in East Africa: A Survey of Test Types, Test Availability, and Test Prices in Kampala, UgandaSerological tests for the diagnosis of active tuberculosis: relevance for IndiaDiagnostics for Developing Countries.The ethics of testing a test: randomized trials of the health impact of diagnostic tests for infectious diseases.Identification of Novel RD1 Antigens and Their Combinations for Diagnosis of Sputum Smear-/Culture+ TB Patients.Detection of Tuberculosis in HIV Co-infected Individuals: Use of Multiple ELISA Responses to 38kDa, Lipoarabinomannan and ESAT- 6 of M. tuberculosisImmunodiagnosis of tuberculosis: state of the art.Economic evaluations of point of care testing strategies for active tuberculosis.A Systematic Review of the State of Economic Evaluation for Health Care in India.Improving access to new diagnostics through harmonised regulation: priorities for actionCommercial serological tests for the diagnosis of active tuberculosis in India: time for introspection.Evaluation of antigen detection test (chromatographic immunoassay): potential to replace the antibody assay using purified 45-kDa protein for rapid diagnosis of tuberculosis.Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection.Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review.Point-of-Care Blood Tests: Do Indian Villagers Have Cultural Objections?
P2860
Q21144619-D6973E1A-0AC4-436E-9984-8C5E7A24C805Q26991633-9E7CF3C7-B757-4B02-A841-880F94599888Q27004505-909FD164-3014-41C7-9776-EC3C76DE323DQ28072960-BECBD5AE-C903-49B9-B0C2-EDB0AD060D5CQ28540733-868B4AD8-9B2B-4477-B300-6FEA0F3A06DDQ28546789-A1ECFDA5-9718-4CBF-B7D8-E0F8956C20B8Q29994616-D62BE18B-9A3E-4A38-8445-7C2C63775C11Q30400766-342830CB-0861-4E41-9AAF-A4BDC351FECEQ34341865-C90475D9-77F2-4361-8A30-EFE5EB8C0D88Q34395434-EC15669B-7AD8-4C00-87B8-14A648595F86Q34413592-4BCC9FCA-0FCD-4A7D-AE24-9D4F23F5B877Q35726650-BAC292C7-CADD-458B-98E6-6B390DEAB8D0Q36107663-694FFC69-2BC0-4F43-96D1-AC02EFDECCC3Q36335270-C3921876-EF72-4C85-8282-4E4E430873EBQ36379606-AF1AEC72-5AF6-4F4E-AC90-CA16E1B016A5Q36538939-7DF9F621-FEE0-4B02-87AD-7DABC9649C04Q36708518-ECDD8BD8-8C92-47AD-B032-BDC06125DC8AQ37949170-08207354-3284-4735-85A1-9BEB40D38496Q38114142-50E189A2-9C0C-4F54-AE3D-5FC9B1B23CB3Q38602629-A18DA6DC-5087-4021-8727-5608E89AA5D0Q42375494-DD9C0428-2FD8-4B9D-AD4D-F4F10EAADB84Q43044146-6D09F65E-CB00-4280-B293-A767493AAFBEQ51762849-B3B96AA0-7657-4E37-B056-8C89F181AD03Q52651829-2AF732C4-3337-4F73-817A-1DF4252A421DQ55016083-147CDE35-1DF6-440F-975F-CB05DC4D4A81Q59128347-FA15A94F-F88B-41FD-B2B8-21D0A815610F
P2860
Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Serological testing versus oth ...... a cost-effectiveness analysis
@ast
Serological testing versus oth ...... a cost-effectiveness analysis
@en
type
label
Serological testing versus oth ...... a cost-effectiveness analysis
@ast
Serological testing versus oth ...... a cost-effectiveness analysis
@en
prefLabel
Serological testing versus oth ...... a cost-effectiveness analysis
@ast
Serological testing versus oth ...... a cost-effectiveness analysis
@en
P2860
P921
P1433
P1476
Serological testing versus oth ...... a cost-effectiveness analysis
@en
P2093
David W Dowdy
P2860
P304
P356
10.1371/JOURNAL.PMED.1001074
P407
P577
2011-08-09T00:00:00Z